Author name: groggles

Special thanks to St. Vincent’s Private Hospital for hosting a Big Aussie Barbie and raising over $1,000 for prostate cancer. Several different volunteers showed their support and effort – Urology nurses, Nursing Education managers, Staff from all around the hospital and even staff family members. They even had some Rugby League Greats attend on the

In her article for the Australian Financial Review, Prostate treatment: when less is more, Jill Margo discusses the emergence of a new hybrid treatment for prostate cancer. Focal therapy is about to become available in Australia. It is still controversial, althoguh manhy consider it a welcome alternative to other more invasice treatments.

In her article for the Australian Financial Review, How MRI works for prostate cancer, Jill Margo looks at the advantages of MRI over ultrasound in locating prostate cancer. Dr Phillip Stricker explains how MRI has a higher chance of locating elusive tumours and allows other treatments, such as surgery and radiotherapy, to be performed with

In her article for the Australian Financial Review, Bucking the biopsy’s brutal bang, Jill Margo investigates progress made in prostate biopsy. Her interview with Dr Phillip Stricker reveals the latest advances in prostate biopsy, how they came about and what they mean to the patient. Read the article to find out how men can now

All of my patients receive questionnaires to assess their quality-of-life in addition to their cancer outcomes. The results were just presented at the Annual Meeting of the Urological Association of America and won First Prize for this presentation – see poster Click here to download a PDF of this poster.

St Vincent’s Hospital recently unveiled the latest surgical robot. The da Vinci Si Surgical System, developed by Intuitive Surgical, provides high definition 3D imaging, better instrumentation and greater access to tighter spaces. Already revolutionising treatment Dr Stricker says ‘In the coming months we will be working to analyse surgical outcomes of those who have undergone

In a study just published by the British Journal of Urology International, the association between nerve-sparing radical prostatectomy and the risk of increased margins – that is, edges of the removed tumour that show cancer cells – is assessed. Looking at a large cohort of patients who underwent nerve-sparing radical prostatectomy, Dr Moore – a

In research recently accepted for publication in the British Journal of Urology International, Dr Stricker – as part of a team of Australian health professionals at the Garvan Institute of Medical Research and St Vincents Prostate Cancer Centre – looked at the way in which the type of cancer at the edges of a removed

St Vincent’s Prostate Cancer Centre, as Chaired by Dr Phillip Stricker, is one of five international sites to engage in a study to assess the pentafecta. The pentafecta is a new concept used to report outcomes of minimally invasive robotic surgery and was championed by Vip Patel. Traditionally surgeons viewed robotic surgery outcomes in terms

Safe and accurate biopsies are essential to the management of prostate cancer. Whilst the transrectal biopsy is more common in Australia, transperineal biopsy potentially has a lower risk of infection rate and better detection of anterior-based tumours. As a leader in the care of men with prostate cancer and a world initiator of the transperineal

Reporter Natasha Johnson’s story, ‘Prostate surgery under the microscope’, looks at the use of robotic surgery in prostate cancer and the research that compares it to traditional open surgery. Leading prostate specialists give their views.

Set to expand the wealth of knowledge and further pioneer the care and treatment of men with prostate cancer, Dr Stricker is this year engaging in a new clinical trial. Having commenced in early 2012 the trial focuses on low risk prostate cancers and the role of Magnetic Resonance Imaging (MRI). Open to all men

Dr Stricker is recognised by Device Technologies for having performed over 700 robotic surgeries. He is presented with the ‘Club 700‘ certificate by Peter Ord of Device Technologies Australia.

On the 3 November 2011 Dr Phillip Stricker completed his 700th robotic case. Dr Stricker’s robotic results show a 96.5% clearance rate in the eradication of early stage prostate cancer and 86% clearance rate in overall cancers. Click here for more on Dr Stricker’s robotic surgery results.

Dr Stricker has commenced a new form of laser therapy for benign prostatic hyperplasia using the biolitic laser technology. This is the first time this has been used in Australia and Dr Stricker is initially performing a trial at St Vincent’s. Preliminary results are excellent with patients being discharged within 24 hours and often within